Identify and study the roles of key genes and proteins in subpopulations of Alzheimer's disease patients with uncoupled neurofibrillary tangles
Identify and study the roles of key genes and proteins in subpopulations of Alzheimer's disease patients with uncoupled neurofibrillary tangles
批准号:
10525012
负责人:
Cristian Lasagna-Reeves
金额:
$42.6万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2024-07-31
关键词:
AffectAgeAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease patientApplications GrantsAxonAxonal TransportBehavioralBiochemicalBioinformaticsBiologicalBrainCandidate Disease GeneCharacteristicsClinicalCognitiveDataData SetDementiaDependovirusDepositionDeteriorationDiseaseDisease ProgressionDisease susceptibilityDrosophila genusDrosophila melanogasterElderlyEtiologyEyeGene ProteinsGenesGenetic ModelsGenetic ScreeningGenomicsGoalsHumanImpaired cognitionImpairmentInjectionsMAPT geneMeasuresMicrotubule BundleMiningMitochondriaModelingMouse StrainsMusNeonatalNeurodegenerative DisordersNeurofibrillary TanglesNeuronsPathogenesisPathologicPathologyPathway interactionsPersonsPlayPopulationPredispositionProteinsProteomicsResearchRoleSamplingScreening procedureSeveritiesStressSubgroupSynapsesTauopathiesTestingToxic effectTransgenic Organismsasymptomatic Alzheimer&aposs diseasecausal variantcurative treatmentsdifferential expressiondisorder subtypedrug developmentexperimental studyflyhuman modelimprovedin vivomouse modeloverexpressionpatient subsetsprecision medicinepreventresiliencetau Proteinstau aggregationtherapeutically effectivetranscriptomics
中文摘要
项目摘要
阿尔茨海默病(AD)影响着美国大约10%的65岁及以上的人口,大约40岁
全世界有一百万人。尽管进行了数十年的研究,但阿尔茨海默病的病因仍不清楚,
直到今天,阿尔茨海默病还没有根治的方法。通常,阿尔茨海默病患者的大脑表现出
神经原纤维缠结(NFT),由与微管相关的聚集束组成
蛋白质tau处于截短或过度磷酸化状态,以及大脑中NFTs的程度通常
与疾病进展、认知功能减退呈正相关。然而,也存在着
疾病轨迹不遵循典型的NFT累积方式的患者亚群。一个
亚组患者的大脑样本显示出类似AD的高NFT,但没有或较低的认知恶化,
而另一亚组患者表现为严重的认知障碍,但NFT病理较低。
研究这些非典型AD亚型,并确定NFT之间这种解偶联的关键因素
病理和认知障碍不仅将提高AD的精准医学水平,而且还将为
关于如何预防和减缓长期疾病期间认知退化的有价值的信息
进步。
在这个项目中,我们的总体假设是转录组、蛋白质组和网络水平
发现非典型NFTs-痴呆非耦合人脑的差异可能有助于
低NFT AD组认知快速恶化机制及痴呆复原力的研究
无症状AD组。我们计划将数据驱动的方法与综合基因组分析相结合
在多个AD蛋白质组和转录组数据集上识别候选基因、蛋白质和
共表达网络在非典型AD的NFTs-痴呆解偶联中起重要作用
病人。已确定的候选基因将在表达的果蝇品系中进一步筛选
人类病理tau基因和蛋白是NTF痴呆的关键因素
解偶联或呈现神经元保护/AD易感性。从以下方面获得有前途的候选人
果蝇的实验将在最早表达人类tau的小鼠品系上进行进一步测试。
在四个月大的时候了解它们在神经元保护或AD易感性方面的作用。我们的长-
学期目标是为进一步申请拨款以阐明NFT-AD提供实验证据
两个亚群背后的解偶联机制,可以为AD开辟新的研究方向
预防以及AD药物的开发。
英文摘要
Project Abstract
Alzheimer’s disease (AD) affects about 10% of the US population of age 65 and up, and roughly 40
million people worldwide. Despite decades of studies, the disease etiology of AD still remains unclear,
and till today, there is no curative treatment for AD. Typically, AD patient brains show characteristic
neurofibrillary tangles (NFTs), which are composed of aggregated bundles of microtubule-associated
protein tau in its truncated or hyperphosphorylated state, and the degree of NFTs in the brain usually
positively correlates with the disease progression and cognitive decline. However, there also exists
subpopulations of patients whose disease trajectories do not follow the typical NFT accumulation way. A
subgroup of patients’ brain samples showed AD-like high NFTs but with no or low cognitive deterioration,
while another subgroup of patients presents severe cognitive impairment but low NFT pathology.
Studying these atypical AD subtypes and identifying key factors in such uncoupling between NFT
pathology and cognitive impairment will not only improve precision medicine in AD, but also provide
valuable information on how to prevent and slow down cognitive deterioration during the long disease
progression.
In this project, our overarching hypothesis is that the transcriptomic, proteomic, and network-level
differences identified for the atypical NFTs-dementia uncoupled human brains can contribute to the
mechanisms of rapid cognitive deterioration in low-NFT AD groups and the dementia resilience in
Asymptomatic AD groups. We plan to apply data-driven approaches with integrative genomic analyses
on multiple AD proteomic and transcriptomic datasets to identify candidate genes, proteins, and
coexpression networks that play important roles in the NFTs-dementia uncoupling in the atypical AD
patients. The identified gene candidates will be further screened in the Drosophila strains expressing
human pathological tau for causal genes and proteins that are key factors for either NTF-dementia
uncoupling or rendering neuron protection/susceptibility to AD. Promising candidates obtained from
Drosophila experiments will be further tested in the mouse strains which can express human tau as early
as four months old to understand their roles in terms of neuron-protection or AD-susceptibility. Our long-
term goal is to generate experimental evidence for further grant applications to elucidate the NFT-AD
uncoupling mechanisms behind the two subgroups, which can open new research directions for AD
prevention as well as AD drug development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tau-seed protein interactome and its role in neurodegenerative tauopathies
-
批准号:10456475
-
项目类别:
-
资助金额:$6.93万
-
财政年份:2021
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
Tau-seed protein interactome and its role in neurodegenerative tauopathies
-
批准号:10407715
-
项目类别:
-
资助金额:$2.63万
-
财政年份:2021
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
Tau-seed protein interactome and its role in neurodegenerative tauopathies
-
批准号:10480212
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2020
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
Tau-seed protein interactome and its role in neurodegenerative tauopathies
-
批准号:10470271
-
项目类别:
-
资助金额:$70.47万
-
财政年份:2020
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
Tau-seed protein interactome and its role in neurodegenerative tauopathies
-
批准号:10683165
-
项目类别:
-
资助金额:$63.76万
-
财政年份:2020
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
Tau-seed protein interactome and its role in neurodegenerative tauopathies
-
批准号:10268217
-
项目类别:
-
资助金额:$69.42万
-
财政年份:2020
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
Tau-seed protein interactome and its role in neurodegenerative tauopathies
-
批准号:10093443
-
项目类别:
-
资助金额:$71.47万
-
财政年份:2020
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
CAA, Tau and Neurodegeneration
-
批准号:9982573
-
项目类别:
-
资助金额:$4.72万
-
财政年份:2018
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
CAA, Tau and Neurodegeneration
-
批准号:10397996
-
项目类别:
-
资助金额:$53.48万
-
财政年份:2018
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
CAA, Tau and Neurodegeneration
-
批准号:9902288
-
项目类别:
-
资助金额:$64.21万
-
财政年份:2018
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
CAA, Tau and Neurodegeneration
-
批准号:9757655
-
项目类别:
-
资助金额:$54.72万
-
财政年份:2018
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
Studying the Physiological Role of Nuak1 in Tau Pathogenesis
-
批准号:9449704
-
项目类别:
-
资助金额:$24.91万
-
财政年份:2015
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
Studying the Physiological Role of Nuak1 in Tau Pathogenesis
-
批准号:9104232
-
项目类别:
-
资助金额:$9.46万
-
财政年份:2015
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
Studying the Physiological Role of Nuak1 in Tau Pathogenesis
-
批准号:8947460
-
项目类别:
-
资助金额:$9.46万
-
财政年份:2015
-
负责人:Cristian Lasagna-Reeves
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: